Barcelona, February 4, 2025
Grifols Teams Up with FcR Therapeutics to Pioneer Recombinant Autoimmune Therapies
Grifols, a global leader in plasma-derived medicines and immunological research, has announced a strategic early-stage collaboration with Utrecht-based biotech startup FcR Therapeutics. The partnership aims to develop innovative recombinant nanobodies targeting Fc receptors, proteins that play a crucial role in triggering autoimmune diseases…